Trazpiroben is an investigational, orally active dopamine D2/D3 receptor antagonist developed primarily for the treatment of gastroparesis. This category encompasses essential reference standards for the… Read more
![Chemical structure of (1,1-Dioxido-8-(phenylsulfonyl)-1-thia-8-azaspiro[4.5]decan-4-yl)(morpholino)methanone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2096147-93-0-11-Dioxido-8-phenylsulfonyl-1-thia-8-azaspiro4.5decan-4-ylmorpholinomethanone.png&w=3840&q=75)






![Chemical structure of 2-(8-Benzyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-3-yl)-N-(4-fluorobenzyl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F941927-85-1-2-8-Benzyl-24-dioxo-138-triazaspiro4.5decan-3-yl-N-4-fluorobenzylacetamide.png&w=3840&q=75)
![Chemical structure of 2-(8-Benzyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-3-yl)acetic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F732926-20-4-2-8-Benzyl-24-dioxo-138-triazaspiro4.5decan-3-ylacetic-Acid.png&w=3840&q=75)
![Chemical structure of 3,8-Bis(4-chlorobenzyl)-1,3,8-triazaspiro[4.5]decane-2,4-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1021100-05-9-38-Bis4-chlorobenzyl-138-triazaspiro4.5decane-24-dione.png&w=3840&q=75)
![Chemical structure of 3-((1-Benzyl-3,3-dimethylpiperidin-4-yl)amino)benzo[d]isothiazole 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2419196-24-8-3-1-Benzyl-33-dimethylpiperidin-4-ylaminobenzodisothiazole-11-dioxide.png&w=3840&q=75)
![Chemical structure of 3-(2,5-Dimethylbenzyl)-8-(2-(o-tolyl)acetyl)-1,3,8-triazaspiro[4.5]decane-2,4-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1574588-31-0-3-25-Dimethylbenzyl-8-2-o-tolylacetyl-138-triazaspiro4.5decane-24-dione.png&w=3840&q=75)
![Chemical structure of 3-(4-Chlorobenzyl)-8-(2-(4-fluorophenyl)acetyl)-1,3,8-triazaspiro[4.5]decane-2,4-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1574616-36-6-3-4-Chlorobenzyl-8-2-4-fluorophenylacetyl-138-triazaspiro4.5decane-24-dione.png&w=3840&q=75)
![Chemical structure of 3-(4-Chlorobenzyl)-8-(2-(o-tolyloxy)acetyl)-1,3,8-triazaspiro[4.5]decane-2,4-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1574634-14-2-3-4-Chlorobenzyl-8-2-o-tolyloxyacetyl-138-triazaspiro4.5decane-24-dione.png&w=3840&q=75)
![Chemical structure of 3-(4-Chlorobenzyl)-8-(2-phenoxyacetyl)-1,3,8-triazaspiro[4.5]decane-2,4-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1021100-97-9-3-4-Chlorobenzyl-8-2-phenoxyacetyl-138-triazaspiro4.5decane-24-dione.png&w=3840&q=75)
![Chemical structure of 3-(4-Chlorobenzyl)-8-(2-phenylacetyl)-1,3,8-triazaspiro[4.5]decane-2,4-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1021211-57-3-3-4-Chlorobenzyl-8-2-phenylacetyl-138-triazaspiro4.5decane-24-dione.png&w=3840&q=75)
![Chemical structure of 3-(4-Methylbenzyl)-8-(2-phenylbutanoyl)-1,3,8-triazaspiro[4.5]decane-2,4-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1574558-86-3-3-4-Methylbenzyl-8-2-phenylbutanoyl-138-triazaspiro4.5decane-24-dione.png&w=3840&q=75)
![Chemical structure of 3-Benzyl-8-(2-(4-chlorophenyl)acetyl)-1,3,8-triazaspiro[4.5]decane-2,4-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1574602-46-2-3-Benzyl-8-2-4-chlorophenylacetyl-138-triazaspiro4.5decane-24-dione.png&w=3840&q=75)

![Chemical structure of 4-(3-Fluorobenzyl)-8-(3-phenylpropanoyl)-1-thia-4,8-diazaspiro[4.5]decan-3-one 1-oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2096243-83-1-4-3-Fluorobenzyl-8-3-phenylpropanoyl-1-thia-48-diazaspiro4.5decan-3-one-1-oxide.png&w=3840&q=75)
![Chemical structure of 4-(8-Benzyl-2,8-diazaspiro[4.5]decane-2-carbonyl)-1-(2-methoxyethyl)pyrrolidin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2224226-34-8-4-8-Benzyl-28-diazaspiro4.5decane-2-carbonyl-1-2-methoxyethylpyrrolidin-2-one.png&w=3840&q=75)
![Chemical structure of 4-Benzyl-8-(2-cyclopropylacetyl)-1-thia-4,8-diazaspiro[4.5]decan-3-one 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2600646-36-2-4-Benzyl-8-2-cyclopropylacetyl-1-thia-48-diazaspiro4.5decan-3-one-11-dioxide.png&w=3840&q=75)
![Chemical structure of 4-Benzyl-8-(cycloheptanecarbonyl)-1-thia-4,8-diazaspiro[4.5]decan-3-one 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2096146-65-3-4-Benzyl-8-cycloheptanecarbonyl-1-thia-48-diazaspiro4.5decan-3-one-11-dioxide.png&w=3840&q=75)
![Chemical structure of 8-((2-Chlorophenyl)sulfonyl)-2-((4-methylpiperazin-1-yl)methyl)-1-oxa-8-azaspiro[4.5]decane](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2096376-12-2-8-2-Chlorophenylsulfonyl-2-4-methylpiperazin-1-ylmethyl-1-oxa-8-azaspiro4.5decane.png&w=3840&q=75)



Trazpiroben is an investigational, orally active dopamine D2/D3 receptor antagonist developed primarily for the treatment of gastroparesis. This category encompasses essential reference standards for the parent drug, alongside a comprehensive selection of pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are critical for pharmaceutical laboratories conducting rigorous analytical testing and method validation throughout the drug development lifecycle. By utilizing these characterized reference standards, researchers can perform precise impurity profiling and identify potential degradants in complex formulations. This ensures accuracy during quantitative analysis and helps maintain stringent quality control protocols required to assess the safety and efficacy of the compound. Access to these high-quality analytical materials supports the development of reliable testing methodologies necessary for regulatory compliance and the systematic monitoring of the drug throughout its investigational stages.